User profiles for Shuwen Liu

Shuwen Liu

Southern Medical University
Verified email at smu.edu.cn
Cited by 32119

[HTML][HTML] Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high …

S Xia, M Liu, C Wang, W Xu, Q Lan, S Feng, F Qi, L Bao… - Cell research, 2020 - nature.com
The recent outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 infection
in Wuhan, China has posed a serious threat to global public health. To develop specific anti-…

[HTML][HTML] The spike protein of SARS-CoV—a target for vaccine and therapeutic development

L Du, Y He, Y Zhou, S Liu, BJ Zheng… - Nature Reviews …, 2009 - nature.com
Severe acute respiratory syndrome (SARS) is a newly emerging infectious disease caused
by a novel coronavirus, SARS-coronavirus (SARS-CoV). The SARS-CoV spike (S) protein is …

[HTML][HTML] Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein

…, M Liu, Q Lan, W Xu, Y Wu, T Ying, S Liu… - Cellular & molecular …, 2020 - nature.com
Similar to severe acute respiratory syndrome (SARS)-CoV, 2019-nCoV belongs to lineage
B betacoronavirus, and it has the ability to utilize human angiotensin-converting enzyme 2 (…

[HTML][HTML] Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and …

S Liu, G Xiao, Y Chen, Y He, J Niu, CR Escalante… - The Lancet, 2004 - thelancet.com
Background Studies on the fusion-inhibitory peptides derived from the heptad repeat 1 and
2 (HR1 and HR2) regions of the HIV-1 envelope glycoprotein gp41 provided crucial …

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine

Y He, Y Zhou, S Liu, Z Kou, W Li, M Farzan… - … and biophysical research …, 2004 - Elsevier
The spike (S) protein of severe acute respiratory syndrome (SARS) coronavirus (CoV), a
type I transmembrane envelope glycoprotein, consists of S1 and S2 domains responsible for …

[HTML][HTML] Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry

W Wu, R Li, X Li, J He, S Jiang, S Liu, J Yang - Viruses, 2015 - mdpi.com
Influenza A viruses (IAVs) cause seasonal pandemics and epidemics with high morbidity
and mortality, which calls for effective anti-IAV agents. The glycoprotein hemagglutinin of …

Archean geodynamics in the Central Zone, North China Craton: constraints from geochemistry of two contrasting series of granitoids in the Fuping and Wutai …

S Liu, Y Pan, Q Xie, J Zhang, Q Li - Precambrian Research, 2004 - Elsevier
The Archean to Paleoproterozoic Central Zone of the North China Craton is situated between
the Eastern and Western Archean continental blocks and contains two contrasting series of …

Th–U–Pb monazite geochronology of the Lüliang and Wutai Complexes: constraints on the tectonothermal evolution of the Trans-North China Orogen

S Liu, G Zhao, SA Wilde, G Shu, M Sun, Q Li… - Precambrian …, 2006 - Elsevier
Recent lithological, metamorphic and geochronological studies show that the basement of
the North China Craton (NCC) formed by collision of two discrete Archean to …

N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus …

S Jiang, H Lu, S Liu, Q Zhao, Y He… - Antimicrobial agents …, 2004 - Am Soc Microbiol
A recently approved peptidic human immunodeficiency virus type 1 (HIV-1) fusion inhibitor,
T-20 (Fuzeon; Trimeris Inc.), has shown significant promise in clinical application for treating …

Geological and isotopic geochemical constraints on the evolution of the Fuping Complex, North China Craton

S Liu, Y Pan, J Li, Q Li, J Zhang - Precambrian Research, 2002 - Elsevier
The Neoarchean to Paleoproterozoic Fuping Complex together with the adjacent Hengshan
and Wutaishan complexes form the middle part of the Central Zone that separates the North …